Comparison of the anti-tumor effects of various whole-body hyperthermia protocols: correlation with HSP 70 expression and composition of splenic lymphocytes
/in Hyperthermia, International Publications, Malignant MelanomaRegional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0
/in Hyperthermia, International Publications, Prostate CancerEffects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer
/in Hyperthermia, International Publications, Newcastle Disease VirusTherapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy
/in Cervical Cancer, Dendritic Cells, International PublicationsThe anti-tumor effect of interleukin-12 is enhanced by mild (fever-range) thermal therapy
/in Hyperthermia, International PublicationsImpact of fever-range thermal stress on lymphocyte-endothelial adhesion and lymphocyte trafficking
/in Hyperthermia, International PublicationsAn important role for granulocytes in the thermal regulation of colon tumor growth
/in Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer